Body mass index and response to neoadjuvant chemotherapy in breast cancer patients

被引：0
|
作者：
Litton, J. K. [1 ]
Gonzalez, A. M. [1 ]
Warneke, C. L. [1 ]
Kau, S. [1 ]
Buzdar, A. U. [1 ]
Bondy, M. [1 ]
Mahabir, S. [1 ]
Hortobagyi, G. N. [1 ]
Brewster, A. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
531
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Clinical verification of body mass index and tumor immune response in patients with breast cancer receiving preoperative chemotherapy
    Takada, Koji
    Kashiwagi, Shinichiro
    Asano, Yuka
    Goto, Wataru
    Ishihara, Sae
    Morisaki, Tamami
    Shibutani, Masatsune
    Tanaka, Hiroaki
    Hirakawa, Kosei
    Ohira, Masaichi
    BMC CANCER, 2021, 21 (01)
  • [22] Clinical verification of body mass index and tumor immune response in patients with breast cancer receiving preoperative chemotherapy
    Koji Takada
    Shinichiro Kashiwagi
    Yuka Asano
    Wataru Goto
    Sae Ishihara
    Tamami Morisaki
    Masatsune Shibutani
    Hiroaki Tanaka
    Kosei Hirakawa
    Masaichi Ohira
    BMC Cancer, 21
  • [23] The Impact of Body Mass Index on the Prognostic Power of Circulating Tumor Cells and Pathologic Complete Response Following Neoadjuvant Chemotherapy for Breast Cancer
    Fayanju, Oluwadamilola
    Hall, Carolyn
    Bauldry, Jessica
    Karhade, Mandar
    Valad, Lily
    Kuerer, Henry
    DeSnyder, Sarah
    Barcenas, Carlos
    Lucci, Anthony
    ANNALS OF SURGICAL ONCOLOGY, 2016, 23 : 71 - 72
  • [24] Body mass index (BMI) is a predictor for response to neoadjuvant chemotherapy in women with localized breast cancer aged 35 years or younger.
    Eralp, Y
    Smith, TL
    Kau, SW
    Valero, V
    Buzdar, A
    Hortobagyi, GN
    Arun, B
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 27S - 27S
  • [25] IMPACT OF BODY MASS INDEX (BMI) ON DISEASE FREE SURVIVAL AND LIKELIHOOD OF PATHOLOGIC COMPLETE RESPONSE IN PATIENTS WITH LOCALLY ADVANCED BREAST CANCER TREATED WITH NEOADJUVANT CHEMOTHERAPY
    Armengol-Alonso, A.
    Arance, A.
    Campayo, M.
    Gonzalez-Farre, X.
    Garcia-Herrera, A.
    Fernandez, P. L.
    Caparros, X.
    Alonso, I.
    Farrus, B.
    Munoz, M.
    ANNALS OF ONCOLOGY, 2012, 23 : 135 - 135
  • [26] High body mass index (BMI) and worse response to neoadjuvant chemotherapy (NACT) by breast cancer phenotype: Own data and external validation on German breast group (GBG) patients
    Vanoppen, M.
    Brouckaert, O.
    Laenen, A.
    Fontanella, C.
    Wildiers, H.
    Paridaens, R.
    Leunen, K.
    Amant, F.
    Berteloot, P.
    Smeets, A.
    Loibl, S.
    Floris, G.
    Christiaens, M-R
    Vergote, I.
    Neven, P.
    CANCER RESEARCH, 2013, 73
  • [27] Optical Mammography in Patients with Breast Cancer Undergoing Neoadjuvant Chemotherapy: Individual Clinical Response Index
    Anderson, Pamela G.
    Kalli, Sirishma
    Sassaroli, Angelo
    Krishnamurthy, Nishanth
    Makim, Shital S.
    Graham, Roger A.
    Fantini, Sergio
    ACADEMIC RADIOLOGY, 2017, 24 (10) : 1240 - 1255
  • [28] A role for immune response in the response to neoadjuvant chemotherapy for breast cancer patients
    Kim, R.
    Kawai, A.
    Wakisaka, M.
    Funaoka, Y.
    Yasuda, N.
    Ohtani, S.
    Ito, M.
    Arihiro, K.
    BREAST, 2017, 32 : S79 - S79
  • [29] RADIONUCLIDE EVALUATION OF RESPONSE TO NEOADJUVANT CHEMOTHERAPY IN BREAST CANCER PATIENTS
    Solodyannikova, O.
    RADIOTHERAPY AND ONCOLOGY, 2010, 94 : S30 - S30
  • [30] Response to neoadjuvant chemotherapy in patients with triple negative breast cancer
    Abe, E.
    Hayashi, N.
    Yoshida, A.
    Hamaoka, T.
    Yagata, H.
    Tsugawa, K.
    Tsunoda-Shimizu, H.
    Suzuki, K.
    Nakamura, S.
    CANCER RESEARCH, 2009, 69 (02) : 367S - 367S
12345